Leukotriene B-4 is the functional ligand binding to and activating the cloned chemoattractant receptor, CMKRL1

被引:27
作者
Owman, C
Sabirsh, A
Boketoft, A
Olde, B
机构
[1] Section of Molecular Neurobiology, Dept. of Physiology and Neuroscience, University of Lund, S-22362, Lund
关键词
D O I
10.1006/bbrc.1997.7628
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We recently described a novel chemoattractant receptor, provisionally named CMKRL1, which has turned out to be the first cloned leukotriene (LT) receptor. Present binding assays using tritiated LTB4 and isolated membranes from COS-7 cells, transiently transfected with cDNA encoding this receptor, yielded a linear Scatchard plot showing expression of only a single, high-affinity receptor population with a mean K-d of 2.1 nM and B-max of 17.0 pmoles/mg protein. Sham-transfected cells exhibited no specific binding. LTB4 elicited concentration-dependent increases in intracellular calcium measured with Fura-2 in individual CI-IO cells stably expressing CMKRL1. No response was seen with sham-transfected control cells, or in calcium-free medium which suggests that calcium mainly originates from extracellular sources. The LTB4-induced cellular calcium increment was blocked in the presence of a monoclonal antibody, raised against a synthetic peptide corresponding to the extracellular tail of CMKRL1 and capable of visualizing the receptor by fluorescence immunocytochemistry. Taken together the analyses show that LTB4 is the endogenous ligand for CMKRL1 which is, thus, identical to the LTB4 receptor, designated BLTR according to the NC-IUPHAR nomenclature. (C) 1997 Academic Press.
引用
收藏
页码:162 / 166
页数:5
相关论文
共 18 条
[1]   Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells [J].
Akbar, GKM ;
Dasari, VR ;
Webb, TE ;
Ayyanathan, K ;
Pillarisetti, K ;
Sandhu, AK ;
Athwal, RS ;
Daniel, JL ;
Ashby, B ;
Barnard, EA ;
Kunapuli, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) :18363-18367
[2]  
ALEXANDER SPH, 1997, TRENDS PHARM SCI S, P50
[3]  
CHUNTHARAPAI A, 1994, J IMMUNOL, V152, P1783
[4]  
DONATH PD, 1996, J EXP MED, V183, P2437
[5]   IDENTIFICATION OF THE MAJOR PHOSPHORYLATION SITES IN HUMAN C5A ANAPHYLATOXIN RECEPTOR IN-VIVO [J].
GIANNINI, E ;
BROUCHON, L ;
BOULAY, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19166-19172
[6]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P2440
[7]   A peptide derived from a beta(2)-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation [J].
Hebert, TE ;
Moffett, S ;
Morello, JP ;
Loisel, TP ;
Bichet, DG ;
Barret, C ;
Bouvier, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (27) :16384-16392
[8]   Lack of nucleotide-promoted second messenger signaling responses in 1321N1 cells expressing the proposed P2Y receptor, p2y7 [J].
Herold, CL ;
Li, Q ;
Schachter, JB ;
Harden, TK ;
Nicholas, RA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (03) :717-721
[9]   LEUKOTRIENE RECEPTORS [J].
METTERS, KM .
JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1995, 12 (2-3) :413-427
[10]  
NG CF, 1991, J IMMUNOL, V147, P3096